Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history includes an added Revision: v3.5.4, replacing the prior v3.5.3 in the sequence of revisions.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s interface revision has been updated from v3.5.2 to v3.5.3, reflecting a change to the system/version display rather than any study record content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history shows the addition of revision v3.5.2 and the deletion of revision v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedNew revision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check108 days agoChange DetectedThe history now includes a new Revision: v3.4.2 entry, and the prior government funding notice and Revision: v3.4.1 entry were removed. These changes relate to page versioning and site notices rather than the trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.